|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/21 | (2006.01) |
| A61K 47/60 | (2017.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 19/04 | (2006.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3215193 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15857703.1 |
| Date of filing the European patent application | 2015-11-06 | |
| (97) | Date of publication of the European application | 2017-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-04 |
| (46) | Date of publication of the claims translation | 2024-01-25 |
| (86) | Number | PCT/US2015/059410 |
| Date | 2015-11-06 |
| (87) | Number | WO 2016/073825 |
| Date | 2016-05-12 |
| (30) | Number | Date | Country code |
| 14192114 | 2014-11-06 | EP |
| (72) |
KLADE, Christoph , AT
ZAGRIJTSCHUK, Oleh , AT
LIN, Ko-Chung , US
|
| (73) |
PharmaEssentia Corporation ,
13F, No. 3 Park (YuanQu) Street
Nangang District, Taipei City 11503,
TW
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Pegilinto interferono dozavimo schema |
| DOSAGE REGIMEN FOR PEGYLATED INTERFERON |
| Payment date | Validity (years) | Amount | |
| 2025-10-27 | 11 | 289.00 EUR |
| 2026-11-06 |